Furthermore, MAFG-AS1 knockdown may inhibit the proliferation, migration, invasion, and tumor growth of sorafenib-resistant HCC cells in vitro, suggesting the potential role of MAFG-AS1 in tumor-promoting drug resistance. The gene discussed is MAFG; the disease is hepatocellular carcinoma.